The latter result is likely due to the well-preserved left ventricular function of the subjects enrolled at the onset of cardiomyopathy, with no sign ischemia; at the same time, this observation suggests the importance of PDE5 inhibition at the onset of cardiomyopathy, to decline early inflammatory biomediators. The gene discussed is PDE5A; the disease is cardiomyopathy.